Network pharmacology shows translational impact in conditions like ischemic stroke, suggesting new strategies in hypertension and peripheral artery disease.
Network and Systems Medicine returns at a time when the discipline has advanced from conceptual foundations to demonstrated translational impact. Network pharmacology and systems approaches now provide clinical proof-of-concept, including synergistic interventions in ischemic stroke, mechanistic stratification of hypertension, and nutritional targeting in peripheral artery disease. These examples illustrate a shift from describing biological complexity to addressing causal mechanisms. Supported by initiatives such as REPO4EU and highlighted at RExPO’25, the journal will serve as a diamond open-access platform for sharing computational models, multi-omics integration, and drug repurposing strategies. Its mission is to accelerate collaboration and innovation across stakeholders and ensure that systems and network medicine deliver tangible patient benefit.
No takes yet. Share an insight, caveat, or question.
Rodríguez‐González et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: